Chanhome Lawan, Khow Orawan, Reamtong Onrapak, Vasaruchapong Taksa, Laoungbua Panithi, Tawan Tanapong, Suntrarachun Sunutcha, Sitprija Siravit, Kumkate Supeecha, Chaiyabutr Narongsak
Snake Farm, Queen Saovabha Memorial Institute, The Thai Red Cross Society, Bangkok 10330, Thailand.
Department of Research and Development, Queen Saovabha Memorial Institute, The Thai Red Cross Society, Bangkok 10330, Thailand.
J Venom Anim Toxins Incl Trop Dis. 2022 Apr 11;28:e20210080. doi: 10.1590/1678-9199-JVATITD-2021-0080. eCollection 2022.
A new pit viper, , has been recently discovered in northern and northwestern Thailand. Envenoming by the other species across several Asian countries has been a serious health problem since their venom is highly hematotoxic. However, the management of bites is required as no specific antivenom is available. This study aimed to investigate the biochemical properties and proteomes of venom (PKV), including the cross-neutralization to its lethality with antivenoms available in Thailand.
PKV was evaluated for its neutralizing capacity (ER), lethality (LD), procoagulant and hemorrhagic effects with three monovalent antivenoms (TAAV, DSAV, and CRAV) and one polyvalent (HPAV) hematotoxic antivenom. The enzymatic activities were examined in comparison with venoms of (TAV), (DSV), (CRV). Molecular mass was separated on SDS-PAGE, then the specific proteins were determined by western blotting. The venom protein classification was analyzed using mass spectrometry-based proteomics.
Intravenous LD of PKV was 0.67 µg/g. ER of HPAV, DSAV and TAAV neutralize PKV at 1.02, 0.36 and 0.12 mg/mL, respectively. PKV exhibited procoagulant effect with a minimal coagulation dose of 12.5 ± 0.016 µg/mL and hemorrhagic effect with a minimal hemorrhagic dose of 1.20 ± 0.71 µg/mouse. HPAV was significantly effective in neutralizing procoagulant and hemorrhagic effects of PKV than those of TAAV, DSAV and CRAV. All enzymatic activities among four venoms exhibited significant differences. PKV proteome revealed eleven classes of putative snake venom proteins, predominantly metalloproteinase (40.85%), serine protease (29.93%), and phospholipase A (15.49%).
Enzymatic activities of PKV are similarly related to other viperid venoms in this study by quantitatively hematotoxic properties. Three major venom toxins were responsible for coagulopathy in PKV envenomation. The antivenom HPAV was considered effective in neutralizing the lethality, procoagulant and hemorrhagic effects of PKV.
最近在泰国北部和西北部发现了一种新的蝰蛇。由于其毒液具有高度血液毒性,在亚洲多个国家,被其他蝰蛇物种咬伤已成为一个严重的健康问题。然而,由于没有特效抗蛇毒血清,因此需要对这种蝰蛇咬伤进行治疗。本研究旨在调查这种蝰蛇毒液(PKV)的生化特性和蛋白质组,包括其与泰国现有抗蛇毒血清对其致死性的交叉中和作用。
用三种单价抗蛇毒血清(TAAV、DSAV和CRAV)和一种多价(HPAV)血液毒性抗蛇毒血清评估PKV的中和能力(ER)、致死性(LD)促凝和出血作用。与竹叶青蛇(TAV)、圆斑蝰蛇(DSV)、舟山眼镜蛇(CRV)的毒液相比,检测其酶活性。在SDS-PAGE上分离分子量,然后通过蛋白质印迹法测定特定蛋白质。使用基于质谱的蛋白质组学分析毒液蛋白质分类。
PKV的静脉注射LD为0.67μg/g。HPAV、DSAV和TAAV对PKV的ER分别在1.02、0.36和0.12mg/mL时中和。PKV表现出促凝作用,最小凝血剂量为12.5±0.016μg/mL,出血作用最小出血剂量为1.20±0.71μg/小鼠。HPAV在中和PKV的促凝和出血作用方面比TAAV、DSAV和CRAV更有效。四种毒液的所有酶活性均表现出显著差异。PKV蛋白质组揭示了11类假定的蛇毒蛋白,主要是金属蛋白酶(40.85%)、丝氨酸蛋白酶(29.93%)和磷脂酶A(15.49%)。
通过定量血液毒性特性,PKV的酶活性与本研究中的其他蝰蛇毒液相似。三种主要的毒液毒素是PKV中毒导致凝血病的原因。抗蛇毒血清HPAV被认为能有效中和PKV的致死性、促凝和出血作用。